eClinical Technology and Industy News

SFA Therapeutics Receives Grant For Drug for Acute Respiratory Distress Syndrome In COVID-19

Excerpt from the press release:

PHILADELPHIAJune 24, 2020PRLog — SFA Therapeutics, Inc. is pleased to announce receipt of a “Save Our Start-ups” (SOS) grant to study SFA005 in the treatment of cytokine storm linked to Acute Respiratory Distress Syndrome (ARDS), which has been experienced by patients infected with COVID-19. This grant was issued by Ben Franklin Technology Partners and the Commonwealth of Pennsylvania.”

Click the button below to read the press release:

Continue Reading The Press Release

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?